Cytarabine and Sinusitis bacterial - a phase IV clinical study of FDA data

Summary:

Sinusitis bacterial is reported as a side effect among people who take Cytarabine (cytarabine), especially for people who are male, 20-29 old, also take Oncovin, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Sinusitis bacterial when taking Cytarabine. It is created by eHealthMe based on reports of 65,319 people who have side effects when taking Cytarabine from the FDA, and is updated regularly.

What is Cytarabine?

Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 65,358 Cytarabine users. Check the latest studies of Cytarabine.

What is Sinusitis bacterial?

Sinusitis bacterial (bacterial infection of sinus) is found to be associated with 181 drugs and 163 conditions by eHealthMe. Check the latest studies of Sinusitis bacterial.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

65,319 people reported to have side effects when taking Cytarabine.
Among them, 12 people (0.02%) have Sinusitis bacterial.

Could Cytarabine cause Sinusitis bacterial?

Among these 12 people:

What is the gender of people who have Sinusitis bacterial when taking Cytarabine? *

female: 0.0 %
male: 100 %

What is the age of people who have Sinusitis bacterial when taking Cytarabine? *

What are other drugs people take besides Cytarabine? *

What are other side effects people have besides Sinusitis bacterial? *

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 7 people, 58.33%
Inappropriate Antidiuretic Hormone Secretion: 4 people, 33.33%
Posterior Reversible Encephalopathy Syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss): 4 people, 33.33%
Conjunctivitis Bacterial (infection of conjunctiva by bacteria): 4 people, 33.33%
Hepatotoxicity (chemical-driven liver damage): 4 people, 33.33%
Hippocampal Sclerosis (neuropathological condition with severe neuronal cell loss and gliosis in the hippocampus): 4 people, 33.33%
Oral Herpes (viral infection of mouth): 4 people, 33.33%
Blindness Cortical: 4 people, 33.33%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 33.33%
Skin Toxicity (skin damage due to toxin/poison): 4 people, 33.33%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 41.67%
Bone Marrow Conditioning Regimen: 4 people, 33.33%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 33.33%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 25.00%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 3 people, 25.00%
T-Cell Lymphoma (a blood cell cancer): 2 people, 16.67%
Posterior Reversible Encephalopathy Syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss): 2 people, 16.67%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 8.33%
Immunodeficiency Disorders: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cytarabine and have Sinusitis bacterial?

- Check whether Sinusitis bacterial is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cytarabine:

Cytarabine (65,358 reports)

Browse all side effects of Cytarabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis bacterial:

Sinusitis bacterial (181 drugs)

Browse all the conditions that are associated with Sinusitis bacterial:

Sinusitis bacterial (163 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cytarabine (the active ingredients of Cytarabine) and Cytarabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.